Analyzing the Composition of Tears and Blood for Discovery of Novel Signatures of Aggressive Prostate Cancer
This trial is active, not recruiting.
|Sponsor||University of Arkansas|
|Start date||January 2012|
|End date||February 2019|
|Trial size||75 participants|
|Trial identifier||NCT01514669, 133719|
The purpose of this research study is to compare profiles in the blood and tears of patients with and without prostate cancer with the goal of developing a method of separating men with aggressive and non-aggressive disease.
time frame: 1 day
Male participants from 35 years up to 80 years old.
Inclusion Criteria: 1. Male, 35-80 years old 2. Patients who present for a routine check-up 3. Patients who present for the evaluation of an abnormal exam or test (elevated PSA, abnormal DRE, etc.) 4. Patients who present for the evaluation of a palpable nodule or induration on prostate exam 5. Patients may present with a biopsy proven prostate cancer from outside physician for inclusion into arms 2 or 3 6. For group 1 a negative prostate biopsy Exclusion Criteria: 1. Patient < 35 or > 81 years of age 2. Concurrent eye infection or trauma 3. Active conjunctivitis 4. Abnormal production of tears (too much or too little) 5. Any other conditions the PI or staff feels will not fulfill the criteria for study entry or will place the subject in a harmful environment 6. Atypia on prostate biopsy report
|Official title||Analyzing the Composition of Tears and Blood for Discovery of Novel Signatures of Aggressive Prostate Cancer|
|Principal investigator||Alan Diekman, Ph.D.|
Call for more information